Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Medication
|
| gptkbp:activeDuring |
Fluoxetine
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
Generic
|
| gptkbp:availableSizes |
10 mg
20 mg 40 mg |
| gptkbp:brand |
gptkb:Sarafem
|
| gptkbp:clinicalTrials |
Long-term effects
Studies on efficacy Comparative studies with other SSRIs Studies on safety |
| gptkbp:contraindication |
Seizures
Hyponatremia Severe allergic reactions Monoamine oxidase inhibitors Allergy to fluoxetine Serotonin syndrome Severe skin reactions |
| gptkbp:dosageForm |
20 mg
Oral capsule |
| gptkbp:endOfLife |
1 to 4 days
|
| gptkbp:formFactor |
Capsule
|
| gptkbp:gestationPeriod |
C
|
| gptkbp:healthcare |
Avoid alcohol
Do not stop abruptly Consult doctor before use with other medications |
| https://www.w3.org/2000/01/rdf-schema#label |
Sarafem
|
| gptkbp:interactsWith |
Aspirin
NSAIDs Warfarin |
| gptkbp:lastProduced |
1994
|
| gptkbp:mandates |
Obsessive-compulsive disorder
Bulimia nervosa Major depressive disorder Panic disorder |
| gptkbp:manufacturer |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:marketedAs |
gptkb:Australia
gptkb:Canada gptkb:European_Union gptkb:United_States |
| gptkbp:nutritionalValue |
Liver
|
| gptkbp:patentStatus |
Patent expired
|
| gptkbp:relatedTo |
gptkb:Prozac
|
| gptkbp:route |
Oral
|
| gptkbp:safetyFeatures |
Monitor for suicidal thoughts
Not recommended for children under 18 |
| gptkbp:sideEffect |
Dizziness
Fatigue Nausea Dry mouth Insomnia |
| gptkbp:storage |
Room temperature
|
| gptkbp:usedFor |
gptkb:Premenstrual_Dysphoric_Disorder
|
| gptkbp:waterManagement |
Urine
|